共 48 条
[1]
Koirala A(2020)Vaccines for COVID-19: the current state of play Paediatr Respir Rev 35 43-49
[2]
Joo YJ(2010)The risk of infections with biologic therapies for rheumatoid arthritis Semin Arthritis Rheum 39 327-346
[3]
Khatami A(2021)Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease Ann Rheum Dis 80 1339-1344
[4]
Chiu C(2021)Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia Lancet 397 671-681
[5]
Britton PN(2021)Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Lancet 397 99-111
[6]
Furst DE(2021)Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial Lancet 396 1979-1993
[7]
Haberman RH(2021)Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial Lancet 21 39-51
[8]
Herati R(2021)Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey RMD Open 7 695-709
[9]
Simon D(2022)Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry Ann Rheum Dis 81 undefined-undefined
[10]
Samanovic M(undefined)undefined undefined undefined undefined-undefined